LMNB1 and prostate carcinoma: In a tissue microarray of prostate cancer patients, decreased levels of lamin A/C and B2 were found to correlate with increased risk of lymph node metastasis and disease-specific death, while increased levels of lamin B1 were associated with disease recurrence [19].